In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

Nobody’s undefeated," said power forward Mark Mitchell, who scored a career high 25 points, of the SEC. “So every team has something they need to work on.” ...

For children with signs of neurological conditions such as autism, epilepsy and global developmental delay, genetic testing can help make the diagnosis, identify possible treatments and determine ...